In this issue... our share tips for May 2024, the latest on our Aggressive Portfolio IX, plus company features and market insight.Looking for recovery Shares...
20 April 2021 – positive test results The AIM-listed developer of advanced diagnostics and cancer therapies has received positive data from the clinical validation of…
16 February 2021 – successful test results The AIM-listed group which focuses on novel cancer immunotherapies and diagnostics has revealed that clinical studies have revealed…
8 February 2021 – partnership agreement The company has announced another partnership agreement to speed up the CE marking of its Covid rapid antigen test…
21 December 2020 – license agreement The AIM-listed developer of cancer therapies and diagnostics has entered into a licence agreement with Astrea Bioseparations for the…
6 Auguat 2020 – Covid-19 Test Manufacturing Partner Avacta has announced that it has appointed BBI Solutions, part of BBI Group, to manufacture the saliva-based…
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
